HHS Cracks Down on Fraud, Streamlines Regulations, and Maintains Essential Services

The biggest headline from the Department of Health and Human Services this week is the relaunch of the DOJ-HHS Working Group focused on enforcing the False Claims Act across healthcare and life sciences. HHS, partnering with the Department of Justice, is doubling down on rooting out fraud, waste, and abuse in federal healthcare programs. Senior officials in HHS’s Office of General Counsel, the Office of Inspector General, and the DOJ’s Commercial Litigation Branch will lead this charge, prioritizing whistleblower engagement and leveraging advanced data analytics to spot red flags in billing and program compliance. According to the working group’s announcement, whistleblowers who successfully flag violations could receive as much as 30 percent of any government recovery, which could mean a big uptick in enforcement actions against providers, pharmaceutical companies, and related organizations. But the HHS hasn’t been all about enforcement—policy updates also hit the headlines this week. A newly released policy outlines exactly when HHS will refer regulatory violations for criminal prosecution, responding to a recent executive order aimed at combating overcriminalization in federal regulations. HHS leadership emphasized that they’re looking for a balanced approach, taking public input on what deserves a criminal referral and promising greater transparency in the reporting of potential offenses. Meanwhile, HHS initiatives continue to shape public health on the ground. The July update to the Hospital Outpatient Prospective Payment System brings new billing instructions and payment changes for providers, a regular—but impactful—move from the Centers for Medicare & Medicaid Services affecting hospitals nationwide. And for families and vulnerable populations, federal court action has temporarily blocked an attempt to dismantle the department itself, meaning programs like Medicaid, Medicare, and key public health efforts remain in place, at least for now, following an injunction won by a coalition of 20 state attorneys general. For American citizens, these moves mean continued access to essential services, stepped-up protection against fraud, and new channels for public input into regulatory enforcement. For businesses and the healthcare sector, the renewed enforcement focus and billing changes mean increased scrutiny, but also more clarity about compliance expectations. State and local governments, especially in regions affected by HHS restructuring and regional office consolidations, will be watching how program delivery and oversight adapt as federal roles shift. And for international partners, HHS’s ongoing focus on public health initiatives signals stability even in the midst of internal transformation. HHS leaders, including Secretary Robert F. Kennedy, Jr., have called on healthcare professionals, organizations, and citizens to remain engaged. If you’re aware of fraud or have opinions on the new regulatory enforcement approach, now is the time This content was created in partnership and with the help of Artificial Intelligence AI.